He was one of the more outstanding fellows to come through," said Dr. Rosenberg, 76, who is widely considered a cancer research luminary. When the fellowship ended in 1988, Dr. Belldegrun became a prominent surgeon at the University of California, Los Angeles, but the two men stayed in touch. Eventually, Dr. Belldegrun, 67, got the entrepreneurial bug. He   a biotech company, Agensys, which was acquired by a bigger company for more than $500 million. 